De Novo Urgency and Retention After Midurethral Sling
A 52-year-old woman underwent retropubic midurethral sling 10 days ago for stress urinary incontinence. She now reports inability to void without straining, a postvoid residual of 220 mL on bladder scan, and new severe urgency with frequency every 45 minutes. She has been empirically treated with antibiotics for a presumed UTI by an outside provider, with no improvement. She is afebrile, urinalysis shows no nitrites and moderate leukocytes, and urine culture is pending. Her preoperative urodynamics showed no detrusor overactivity, and her preoperative PVR was 15 mL. She is tearful and asks whether the sling 'ruined her bladder.'
1. What is your differential diagnosis and immediate management plan for this postoperative presentation?
Read the worked answer
The differential is broad and includes both expected postoperative phenomena and serious complications:
- Postoperative urinary retention / voiding dysfunction from sling obstruction or perioperative edema - most likely given the timeline and elevated PVR.
- Urinary tract infection - culture pending; prior empiric antibiotics may have partially treated or selected organisms.
- Bladder outlet obstruction from sling tension, hematoma, or mesh malposition.
- De novo detrusor overactivity unmasked by surgery or irritation from the sling.
- Bladder or urethral injury (occult perforation at time of sling placement) - should be excluded; she had no reported intraoperative cystoscopy? Must be confirmed.
- Hematoma/abscess - she is afebrile, which is reassuring but not exclusionary.
Immediate plan:
- Confirm culture and treat appropriately; do not assume UTI is the cause of retention.
- Measure PVR (already 220 mL - significant) and consider intermittent self-catheterization or indwelling catheter to protect the upper tracts and allow detrusor recovery. A trial of voiding with catheter removal and repeat PVR is reasonable.
- Review operative record for cystoscopy findings and sling tensioning.
- Imaging if concern for hematoma or mesh malposition (ultrasound or MRI).
- Reassurance and education - this is often transient; avoid premature reoperation.
I would not immediately cut the sling. Most early voiding dysfunction improves with drainage and time.
2. At what point, and with what evidence, would you proceed to sling release or division? What are the consequences?
Read the worked answer
Timing is a judgment call. Reasonable practice:
- Early (days to ~2 weeks): conservative management - catheter drainage, treat infection, consider a short course of an alpha-blocker or muscle relaxant (limited evidence), and reassess. Many patients recover voiding.
- Persistent retention beyond ~2–4 weeks with documented obstruction (elevated PVR, straining, poor flow, elevated detrusor pressure on repeat urodynamics if performed) and failure of conservative measures warrants intervention.
- Sling release (loosening, e.g., via a small vaginal incision and dividing the suburethral portion or loosening the tape) is preferred over complete removal when possible, because it preserves some continence benefit. Complete division/removal is reserved for severe obstruction, mesh erosion, or failed release.
Evidence: observational series show high rates of resolution of retention after release/division, but a substantial proportion develop recurrent stress incontinence (roughly a third to half in many series). This must be counseled explicitly.
Before release, I would confirm the diagnosis with repeat urodynamics or at least pressure-flow study if the picture is unclear, and exclude infection and hematoma. I would also involve the patient in shared decision-making, since trading retention for recurrent stress incontinence is a real trade-off.
3. She undergoes sling release and her urgency resolves but she now has recurrent stress incontinence. How do you counsel her, and what are the options?
Read the worked answer
This is the expected trade-off and should be framed honestly: release treated the obstruction at the cost of continence.
Counseling:
- Recurrent stress incontinence after release is common; it is not a failure of her or of the surgeon.
- Options include pelvic floor physical therapy (first-line, low risk), a pessary (continence pessary), and, if bothersome and she desires surgery, a repeat anti-incontinence procedure.
- A repeat sling is feasible but has higher risk of recurrent obstruction and mesh complications; some surgeons prefer a different approach (e.g., autologous fascia or a different sling type) after prior mesh. Burch colposuspension is an alternative in the appropriate patient.
- She should be counseled that repeat procedures have lower success and higher complication rates than primary surgery.
I would start with conservative measures, document bother with a diary, and only offer repeat surgery if she has bothersome, urodynamically confirmed stress incontinence and understands the trade-offs. This case also highlights the value of preoperative counseling about voiding dysfunction risk and the importance of a low threshold for PVR checks in the early postoperative period.